CombinatoRx plunges on Synavive trial failure - Forbes

CombinatoRx plunges on Synavive trial failure
Forbes -48 minutes ago
AP 10.06.08, 10:04 AM ET The drug candidate Synavive missed its main goal in a clinical trial, developer CombinatoRx Inc. said Monday, as the drug did not significantly improve symptoms of osteoarthritis of the knee compared with a placebo.
UPDATE 1-CombinatoRx says drug fails trial, shares slumpReuters
CombinatoRx Slides In Pre-Market On Disappointing Knee RTT News
Boston Globe - Business Wire (press release) - RTT News
all 23 news articles

More: continued here

Leave a Comment for CombinatoRx plunges on Synavive trial failure - Forbes